Kidney Disease Clinical Trial
Official title:
The Effects of a Nurse-led Case Management Programme on Home Exercise Training for Haemodialysis Patients
Verified date | February 2014 |
Source | The Hong Kong Polytechnic University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Hong Kong: Ethics Committee |
Study type | Interventional |
The purpose of this study is to examine the effects of a nurse-led case management programme
on home exercise training for haemodialysis patients. We hypothesised that: a. There is no
significant difference in physical functioning between participants receiving the nurse-led
home exercise training programme and those receiving the comparison care. b. There is no
difference in depression between participants receiving the nurse-led home exercise training
programme and those receiving the comparison care. c. There is no difference in quality of
life and health perception between participants receiving the nurse-led home exercise
training programme and those receiving the comparison care. d. There is no difference in
physical activity levels between participants receiving the nurse-led home exercise training
programme and those receiving the comparison care. e. There is no difference in perceived
benefits and barriers of exercise between participants receiving the nurse-led home exercise
training programme and those receiving the comparison care.
The study was a randomized controlled trial conducted in two haemodialysis units of two
tertiary hospitals in Nanjing, China. Participants were randomly assigned to either study
group or comparison group. Participants in both groups received the in-center exercise
training (20 minutes) before haemodialysis sessions weekly for 6 weeks and were instructed
to perform exercise at home. The in-center training was focused on flexibility and
strengthening exercise. Patients were encouraged to have cardiovascular exercises at home
which will improve their cardiovascular conditions and endurance. The list of cardiovascular
exercise included brisk walking, bicycling, jogging. Participants in the study group were
instructed to start walking or brisk walking at low duration and gradually progress to a
maximum of 30 minutes daily per week. To facilitate exercise progression, the nurse case
managers discussed exercise benefits, explored exercise barriers and developed mutual goals
with patients. The nurse motivated them and checked the exercise behaviors to ensure
adherence to the recommended exercise regime. The nurse case managers interviewed the study
group patients weekly for six weeks and biweekly for another six weeks. Participants in the
comparison group only participated in the in-center exercise training. The comparison group
patients received usual care from the nurse without the interviews and mutual goals
developed.
Status | Completed |
Enrollment | 113 |
Est. completion date | December 2013 |
Est. primary completion date | December 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 19 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Dialysis for >3 months; - Age > 18 years; - Kt/V (dialysis adequacy) >1.2; - Hemoglobin level > 8g/dl; - Ambulatory without assistance ; - Able to communicate in Chinese; - Able to and willing to provide consent. Exclusion Criteria: - Unstable physical conditions or severe musculoskeletal diseases that might hinder exercise training; - Severe hearing impairment; - Diagnosed with mental diseases; - Meeting or exceeding the exercise recommendation. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
China | The First Affiliated Hospital with Nanjing Medical University | Nanjing | Jiangsu |
China | The Second Affiliated Hospital with Nanjing Medical University | Nanjing | Jiangsu |
Lead Sponsor | Collaborator |
---|---|
The Hong Kong Polytechnic University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in walking speed on the 10-meter walking test at week 6 and change from baseline in walking speed on 10-meter walking test at week 12 | Baseline, Week 6, and Week 12 | No | |
Secondary | Change from baseline in time in completing the 10-repetition sit-to-stand test (10-STS) at week 6, and change from baseline in time in completing 10-STS at week 12 | Baseline, Week 6, and Week 12 | No | |
Secondary | Change from baseline in perceived exercise benefits and barriers on the Dialysis Patient-perceived Exercise Benefits and Barriers Scale (DPEBBS) at week 6 and change from baseline in the DPEBBS score at week 12 | Baseline, Week 6, and Week 12 | No | |
Secondary | Change from baseline in health-related quality of life on the Kidney Disease Quality of Life Questionnaire (KDQOL-36) at week 6, and change from baseline in KDQOL-36 score at week 12 | Baseline, Week 6, and Week 12 | No | |
Secondary | Change from baseline in depressive symptoms on the Beck Depression Inventory (BDI) at week 6, and change from baseline in BDI score at week 12 | Baseline, Week 6, and Week 12 | No | |
Secondary | Change from baseline in self-perceived health in the first item in the Kidney Disease Quality of Life Questionnaire at week 6, and change from baseline in self-perceived health score at week 12 | Baseline, Week 6, and Week 12 | No | |
Secondary | Change from week 6 in physical activity levels measured by exercise log at week 12 | Week 6 and Week 12 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02369354 -
Transplant Social Worker Support for Live Kidney Donation in African Americans
|
N/A | |
Not yet recruiting |
NCT02225782 -
Trial to Compare 1.0 Versus 2.0 mg Alteplase (tPA) Dosing in Restoring Hemodialysis Catheter Function
|
Phase 4 | |
Completed |
NCT00499187 -
Fanconi Syndrome Due to ARVs in HIV-Infected Persons
|
Phase 4 | |
Withdrawn |
NCT00585429 -
Evaluation of Kidney Disease in Liver Transplant Recipients
|
N/A | |
Completed |
NCT00379899 -
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
|
Phase 4 | |
Completed |
NCT00183248 -
Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
|
Phase 1/Phase 2 | |
Completed |
NCT00001835 -
Oxaliplatin in Cancer Patients With Impaired Kidney Function
|
Phase 1 | |
Completed |
NCT01331941 -
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
|
Phase 1 | |
Terminated |
NCT00436748 -
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
|
Phase 3 | |
Completed |
NCT01467466 -
Prevention of Serious Adverse Events Following Angiography
|
Phase 3 | |
Completed |
NCT01235936 -
Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia
|
Phase 2 | |
Completed |
NCT01974999 -
A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study
|
||
Completed |
NCT01947829 -
Interdialytic Kt/V Variability Measurement With Adimea (IVP STUDY)
|
N/A | |
Recruiting |
NCT01240564 -
The Nephrotic Syndrome Study Network (NEPTUNE)
|
N/A | |
Active, not recruiting |
NCT01228903 -
Uric Acid and the Endothelium is CKD
|
N/A | |
Completed |
NCT00734357 -
Comparative Investigation of Intravenously Administered Omnipaque and Isovue: Effects on Serum Creatinine Concentration in Outpatients
|
N/A | |
Completed |
NCT00781417 -
Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease
|
N/A | |
Completed |
NCT00185159 -
Olmesartan Medoxomil in Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT00093977 -
Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease
|
Phase 3 | |
Completed |
NCT00096915 -
Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
|
Phase 3 |